Company Opiant Pharmaceuticals, Inc.
Equities
OPNT
US6837501039
Biotechnology & Medical Research
Business Summary
Number of employees: 38
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ryan Preblick
DFI | Director of Finance/CFO | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 5,268,677 | 4,860,817 ( 92.26 %) | 0 | 92.26 % |
Company contact information
Opiant Pharmaceuticals, Inc.
10710 Midlothian Turnpike Suite 125
23235, Richmond
+
https://www.opiant.comSector
1st Jan change | Capi. | |
---|---|---|
-3.46% | 102B | |
+1.41% | 96.29B | |
+2.13% | 22.18B | |
-15.84% | 21.2B | |
-9.21% | 18.31B | |
-39.98% | 17.38B | |
-14.65% | 16.36B | |
+4.39% | 13.97B | |
+31.35% | 12.17B |